Check-Cap (MBAI) Liabilities and Shareholders Equity (2014 - 2025)
Check-Cap's (MBAI) quarterly Liabilities and Shareholders Equity came in at $3.4 million in Q4 2025, up 1763.65% year-on-year from $184940.0 in Q4 2024, and down 40.2% quarter-over-quarter from $5.8 million in Q2 2025.
Check-Cap (MBAI) Liabilities and Shareholders Equity (2014 - 2025) Analysis & Trends
Check-Cap has disclosed Liabilities and Shareholders Equity across 12 years of filings, most recently posting $3.4 million for Q4 2025.
- Liabilities and Shareholders Equity for Q4 2025 came in at $3.4 million, up 1763.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $27.5 million (down 62.0% YoY), and the FY2025 annual result was $3.4 million, up 1763.65% from the prior year.
- Liabilities and Shareholders Equity came in at $3.4 million for Q4 2025 at Check-Cap, down from $5.8 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $60.6 million in Q3 2021 to a low of $184940.0 in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $35.1 million (2021), against an average of $34.4 million.
- Across the five-year window, Liabilities and Shareholders Equity sank 99.26% in 2024 and jumped 1763.65% in 2025, its largest moves.
- Check-Cap's Liabilities and Shareholders Equity stood at $55.7 million in 2021, then dropped by 18.36% to $45.4 million in 2022, then tumbled by 44.95% to $25.0 million in 2023, then tumbled by 99.26% to $184940.0 in 2024, then surged by 1763.65% to $3.4 million in 2025.
- The last three Liabilities and Shareholders Equity figures came in at $3.4 million (Q4 2025), $5.8 million (Q2 2025), and $184940.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 24.53 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 113.28 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 83.54 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 3.39 Bn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 13.07 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 2.61 Bn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 29.68 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 6.56 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.67 Bn |
| 10 | Check-Cap | 207.48 Mn | 207.48 Mn | - | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.45 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Dec 31, 2024 | 184,940.00 |
| Jun 30, 2024 | 18.09 Mn |
| Dec 31, 2023 | 25.02 Mn |
| Sep 30, 2023 | 29.03 Mn |
| Jun 30, 2023 | 33.73 Mn |
| Mar 31, 2023 | 41.31 Mn |
| Dec 31, 2022 | 45.44 Mn |
| Sep 30, 2022 | 49.55 Mn |
| Jun 30, 2022 | 54.13 Mn |
| Mar 31, 2022 | 59.59 Mn |
| Dec 31, 2021 | 55.66 Mn |
| Sep 30, 2021 | 60.58 Mn |
| Jun 30, 2021 | 32.61 Mn |
| Mar 31, 2021 | 36.52 Mn |
| Dec 31, 2020 | 19.64 Mn |
| Sep 30, 2020 | 23.19 Mn |
| Jun 30, 2020 | 17.88 Mn |
| Mar 31, 2020 | 10.60 Mn |